340 related articles for article (PubMed ID: 21533771)
1. Contribution of cancer stem cells to tumor vasculogenic mimicry.
Yao XH; Ping YF; Bian XW
Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
3. The origins of vacularization in tumors.
Liu J; Huang J; Yao WY; Ben QW; Chen DF; He XY; Li L; Yuan YZ
Front Biosci (Landmark Ed); 2012 Jun; 17(7):2559-65. PubMed ID: 22652798
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition and Vascular Mimicry in Breast Cancer Stem Cells.
Kotiyal S; Bhattacharya S
Crit Rev Eukaryot Gene Expr; 2015; 25(3):269-80. PubMed ID: 26558950
[TBL] [Abstract][Full Text] [Related]
7. [Research progress in vasculogenic mimicry in
multiple tumors].
Bai J; Xu Z; Liao C; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
[TBL] [Abstract][Full Text] [Related]
9. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions.
Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J
J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase mediates transforming growth factor-β1-induced vasculogenic mimicry formation: involvement of the epithelial-mesenchymal transition and cancer stemness activity.
Zhang X; Zhang J; Zhou H; Liu G; Li Q
Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):411-420. PubMed ID: 32296834
[TBL] [Abstract][Full Text] [Related]
11. Slug promoted vasculogenic mimicry in hepatocellular carcinoma.
Sun D; Sun B; Liu T; Zhao X; Che N; Gu Q; Dong X; Yao Z; Li R; Li J; Chi J; Sun R
J Cell Mol Med; 2013 Aug; 17(8):1038-47. PubMed ID: 23815612
[TBL] [Abstract][Full Text] [Related]
12. USP44+ Cancer Stem Cell Subclones Contribute to Breast Cancer Aggressiveness by Promoting Vasculogenic Mimicry.
Liu T; Sun B; Zhao X; Li Y; Zhao X; Liu Y; Yao Z; Gu Q; Dong X; Shao B; Lin X; Liu F; An J
Mol Cancer Ther; 2015 Sep; 14(9):2121-31. PubMed ID: 26232424
[TBL] [Abstract][Full Text] [Related]
13. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
14. Vasculogenic mimicry and tumor metastasis.
Zhang J; Qiao L; Liang N; Xie J; Luo H; Deng G; Zhang J
J BUON; 2016; 21(3):533-41. PubMed ID: 27569069
[TBL] [Abstract][Full Text] [Related]
15. Advanced research on vasculogenic mimicry in cancer.
Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
[TBL] [Abstract][Full Text] [Related]
16. Vasculogenic mimicry in carcinogenesis and clinical applications.
Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
[TBL] [Abstract][Full Text] [Related]
17. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
[TBL] [Abstract][Full Text] [Related]
18. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.
Li S; Meng W; Guan Z; Guo Y; Han X
Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049
[TBL] [Abstract][Full Text] [Related]
20. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin.
Delgado-Bellido D; Serrano-Saenz S; Fernández-Cortés M; Oliver FJ
Mol Cancer; 2017 Mar; 16(1):65. PubMed ID: 28320399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
